GGrantIndex
← Leaderboards

Alchem Laboratories Corporation

Alachua, FL

Compare ↔
$16,110,807
Total funding
11
Grants

Funding over time

peak $1.7M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,155,383 · 10
DOD$955,424 · 1

By mechanism

N02$15,137,188 · 8
$955,424 · 1
N01$18,195 · 2

Investigators at Alchem Laboratories Corporation

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

SCREENING AND DEVELOPMENT OF SMALL MOLECULE VENEZUELAN EQUINE ENCEPHALITIS VIRUS (VEEV) NON- STRUCTURAL PROTEIN 2 CYSTEINE PROTEASE INHIBITORS$955,424
· FY2025 · Defense Threat Reduction Agency
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies$674,121
N02 · FY2019 · CA
IGF::OT::IGF Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies$671,205
N02 · FY2018 · CA
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 1)$656,366
N02 · FY2023 · CA
MANUFACTURE OF BULK CHEMICALS AND BULK PHARMACEUTICAL INGREDIENTS FOR PRECLINICAL$646,143
N02 · FY2016 · CA
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 1)$637,251
N02 · FY2022 · CA
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$627,585
N02 · FY2020 · CA
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (CONTINUITY FOR 66C)$618,688
N02 · FY2021 · CA
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies$611,276
N01 · FY2021 · CA
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND$578,722
N02 · FY2013 · CA
MANUFACTURE OF BULK CHEMICALS AND BULK PHARMACEUTICAL INGREDIENTS FOR PRECLINICA$576,137
N02 · FY2013 · CA
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$549,643
N02 · FY2018 · CA
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$535,826
N02 · FY2017 · CA
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$522,411
N02 · FY2016 · CA
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$503,874
N02 · FY2019 · CA
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND$492,866
N02 · FY2016 · CA
Manufacture of Bulk Chemicals and Bulk Pharmaceutical Ingredients for Preclinical and Clinical Studies$432,304
N01 · FY2020 · CA
Manufacture of Bulk Chemical and Bulk Pharmaceutical Ingredients$421,186
N01 · FY2009 · CA
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND$416,410
N02 · FY2012 · CA
Synthesis support for early stages of drug discovery and development program$412,782
N02 · FY2017 · CA